TrialBreast cancer research : BCR2020

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.

Christine Lundgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.